Successful treatment of brain aspergillosis with voriconazole

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
P TattevinB Régnier

Abstract

Until recently, brain aspergillosis was almost always fatal, with a response rate to amphotericin B of < 10%. This study describes a retrospective analysis of eight consecutive cases of brain aspergillosis. All patients were immunosuppressed and five required mechanical ventilation. Antifungal treatment included amphotericin B (n = 7), itraconazole (n = 3), voriconazole (n = 2) and flucytosine (n = 1). Three (38%) patients survived following prolonged azole therapy after initial amphotericin B treatment, combined with a reduction in their immunosuppressive treatment. The prognosis of brain aspergillosis might be improved if immunosuppression could be reduced and prolonged oral azole therapy used.

References

Jul 13, 1974·Lancet·G Teasdale, B Jennett
Nov 1, 1972·American Journal of Clinical Pathology·R C YoungJ E Bennett
Aug 1, 1994·The American Journal of Medicine·D W DenningA Catanzaro
Jan 1, 1996·Scandinavian Journal of Infectious Diseases·C Darras-JolyM Wolff
Sep 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D W Denning
Dec 1, 1996·Intensive Care Medicine·J J JanssenP C Huijgens
Jun 13, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D W Denning
Nov 30, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E J DasbachS M Teutsch
Dec 4, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S AsciogluUNKNOWN Mycoses Study Group of the National Institute of Allergy and Infectious Diseases
Jan 25, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David W DenningHartmut Lode
Mar 21, 2002·Neurosurgery·Ersin ErdoganBülent Celasun
Aug 9, 2002·The New England Journal of Medicine·Raoul HerbrechtUNKNOWN Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillu
Aug 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Irja LutsarPeter Troke
Oct 1, 1959·Diseases of the Chest·V A KELMENSON

❮ Previous
Next ❯

Citations

May 6, 2005·Journal of Clinical Microbiology·M A PfallerD J Diekema
Mar 25, 2008·Therapeutics and Clinical Risk Management·Javier PemánMiguel Gobernado
Oct 13, 2009·Revue neurologique·I LouatiR Mrissa
Dec 3, 2014·Revista iberoamericana de micología·José Ramón AzanzaAlmudena Gómez-Guíu
Mar 28, 2006·International Journal of Antimicrobial Agents·Dominique LevêqueRaoul Herbrecht
Oct 7, 2005·Expert Review of Anti-infective Therapy·Livio PaganoLuana Fianchi
Apr 27, 2021·Neurologic Clinics·Caleb R S McEntireAnna M Cervantes-Arslanian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Mohanad BaklehWilliam F Marshall
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
G PozaE Simarro
© 2021 Meta ULC. All rights reserved